Tetrahydrocannabinol (THC) pharmacology
Pro Research Analysisby 
Searched over 200M research papers
THC Pharmacology: Cannabinoid Receptor Activity and Mechanisms
Δ9-Tetrahydrocannabinol (THC) is the main psychoactive compound in cannabis, acting primarily as a partial agonist at both CB1 and CB2 cannabinoid receptors. The effects of THC depend on the expression and signaling efficiency of these receptors, as well as the presence of endogenous cannabinoids in the body. THC’s interaction with these receptors underlies its psychotropic, analgesic, anti-inflammatory, anti-nausea, and immunosuppressive properties, making it relevant for various medical applications 13.
THC Metabolism and Pharmacokinetics
THC is mainly metabolized in the liver by cytochrome P450 enzymes, especially CYP2C9 and CYP3A4. Its primary active metabolite is 11-hydroxy-THC (11-OH-THC), which is itself psychoactive and may be as potent or even more potent than THC in certain effects, such as pain relief and catalepsy. The inactive metabolite is 11-nor-9-carboxy-THC (THC-COOH) 678. The route of administration (inhalation vs. injection) significantly affects the pharmacokinetics: inhalation leads to higher initial brain THC concentrations, while injection results in higher levels of 11-OH-THC in both blood and brain .
Pregnancy and associated hormonal changes can induce the enzymes that metabolize THC, potentially altering its pharmacokinetics and effects in pregnant individuals . Additionally, drug interactions with CYP3A4 inhibitors (like ketoconazole) can increase THC levels in the body .
Dose-Response and Individual Variability
THC serum concentrations increase linearly with higher doses, and this is associated with stronger pharmacological effects such as increased heart rate and the sensation of being "high." However, there is significant variability between individuals in how much THC is absorbed and how strongly it affects them .
Sex Differences in THC Effects
Research in animal models shows that there are sex-dependent differences in THC metabolism and effects. For example, female rats have higher levels of the active metabolite 11-hydroxy-THC, and both behavioral and neural responses to THC can differ between males and females 49.
Comparative Pharmacology: Δ8-THC and Other Cannabinoids
Δ8-THC, a structural isomer of Δ9-THC, has similar pharmacokinetics and pharmacodynamics but is generally less potent due to weaker CB1 receptor affinity. Both Δ8-THC and Δ9-THC act as partial agonists at CB1 receptors and produce similar cannabimimetic effects, though Δ8-THC is considered to have a milder effect profile 210. Other cannabinoids, such as cannabidiol (CBD) and tetrahydrocannabivarin (THCV), interact differently with cannabinoid receptors and can modulate the effects of THC .
Therapeutic and Adverse Effects
THC has demonstrated potential as an analgesic, anti-inflammatory, anti-nausea, anticancer, and immunosuppressive agent. However, its use is limited by side effects, including psychotropic effects and the potential for tolerance development. The balance between therapeutic benefits and adverse effects is influenced by dose, route of administration, individual metabolism, and receptor expression 1310.
Conclusion
THC’s pharmacology is complex, involving partial agonism at cannabinoid receptors, active metabolites, and significant variability based on sex, dose, route of administration, and individual metabolism. Its therapeutic potential is balanced by notable side effects, and ongoing research is needed to better understand its mechanisms and optimize its medical use 1234+6 MORE.
Sources and full results
Most relevant research papers on this topic